These two incretin hormones play a crucial role in glycemic control
Now, the first clinical trial although relatively small and limited in duration has confirmed it
Wu J, Zhou R, Zhang Q et al (2024) Safety, pharmacokinetics, and pharmacodynamics of HRS-7535, a novel oral small molecule glucagon-like peptide-1 receptor agonist, in healthy subjects:a phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose, and food effect trial
even at modest concentrations the intrinsic blue-teal hue of the copper complex will tint the finished product, which should be accounted for in the color and packaging strategy
Autolus backed Aucatzyl with data from the Phase II FELIX study, which showed a 63% overall complete remission rate, including 51% of patients who achieved complete remission
That constant decision-making is exhausting